Inhibitors of proteasomal activity for stimulating hair growth
Patent 6838252 Issued on January 4, 2005. Estimated Expiration Date: January 15, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
435/23, Involving proteinase435/6, Involving nucleic acid514/880, HAIR TREATMENT (THERAPEUTIC-SCALP)530/350, PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES514/457, Coumarins (including hydrogenated)514/263.35, Nitrogen attached indirectly to the purine ring system by acyclic nonionic bonding514/18, 3 or 4 peptide repeating units in known peptide chain548/472, Chalcogen bonded directly to ring carbon of the five-membered hetero ring (e.g., phthalimidines, etc.)514/526, Acyclic514/64, Boron containing DOAI514/12, 25 or more peptide repeating units in known peptide chain structure548/453, Plural ring hetero atoms in the bicyclo ring system, or ring nitrogen is shared by the two cyclos of the bicyclo ring system514/100Polycyclo ring system having the hetero ring as one of the cyclos
The present invention relates to compounds that inhibit the activity of the proteasome or the production of proteasomal proteins and promote the production of hair follicles and are thus useful in stimulating hair growth, including hair density, in subject where this is desirable.
Other References
Vinitsky A. Inhibition of the Proteolytic Activity of the Multicatalytic Proteinase Complex (Proteasome) . . . J of Biological Chemistry 269(47)29660-6, 1994.*
Figueiredo-Pereira M. A New Inhibitor of the Chymotrypsin Like Activity . . . J of Neurochemistry 63:1578-81, 1994.*
Wojcik C. Ubiquitin Mediated Proteolysis Centers in HeLa Cells . . . Eur J of Cell Biology 71 311-318, 1996.*
Abu-Amer et al., “NF-kB and Bone: The Breaking Point,” Nature Medicine (1997) 3(11):1189-1190.
Adams, J. et al., “Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents,” Cancer Res (1999) 59:2615-2622.
Adams et al., “Chapter 28. Novel Inhibitors of the Proteasome and their Therapeutic Use in Inflammation,” Annual Reports in Medicinal Chemistry (1996) 279-288.
Ahmed et al., “Alopecia Universalis Associated with a Mutation in the Human Hairless Gene,” Science (1998) 279:720-724.
Bangham et al., “Diffusion of Univalent Ions Across the Lamellae of Swollen Phospholipids,” J Mol Biol (1965) 23:238-252.
Barnes et al., “Nuclear Factor -kB—A Pivotal Transcription Factor in Chronic Inflammatory Diseases,” New Engl J Med (1997) 336:1066-1071.
Baumeister et al., “The Proteasome:Paradigm of a Self-Compartmentalizing Protease,” Cell( 1998) 92:367-380.
Beck et al., “Rapid Publication TGF-β1 Induces Bone Closure of Skull Defects,” J Bone Miner Res (1991) 6(11):1257-1265.
Bellows et al., “Determination of the Capacity for Proliferation and Differentiation of Osteoprogenitor Cells in the Presence and Absence and Absence of Dexamethasone,” Develop Biol (1990) 140:132-138.
Blessing et al., “Transgenic Mice as a Model to Study the Role of TGF-β-Related Molecules in Hair Follicles,” Genes and Develop (1992) 7:204-215.
Burgener et al., “Fluoride Increase Tyrosine Kinase Activity in Osteoblast-like Cells: Regulatory Role for the Stimulation of Cell Proliferation and Pi Transport Across the Plasma Membrane,” J Bone Miner Res (1995) 10:164-171.
Caplan, “Mesenchymal Stem Cells” J Orthop Res (1991) 9:641-650.
Casez et al., “Dual-Energy X-Ray Absorptiometry for Measuring Total Bone Mineral Content in the Rat:Study of Accuracy and Precision,” Bone and Miner (1994) 26:61-68.
Combaret, L. et al., “Manipulation of the Ubiquitin-Proteasome Pathway in Cachexia: Pentoxifylline Suppresses the Activation of 20S and 26S Proteasoms in Muscles from Tumor-Bearing Rats,” Mol Biol Rep (1999) 26:95-101.
Coux, O. et al., “Structure and Functions of the 20S and 26S Proteasomes,” An Review Biochem (1996) 65:801-847.
Craiu, A. et al., “Lactacystin and Clasto-Lactacystin β-Lactone Modify Multiple Proteasome β-Subunits and Inhibit Intracellular Protein Degradation and major Histocompatibility Complex Class I Antigen Presentation,” J Biol Chem (1997) 272:13437-13445.
Cui et al., “Lovastatin Prevents Steroid-Induced Adipogenesis and Osteoporosis,” ASBMR 18th Annual Meeting (Sep. 1996) J Bone Miner Res (1996) 11(S1):S510.
Ducy et al. “Increased Bone Formation in Osteocalcin-deficient Mice,” Nature (1996) 382:448-425.
Edelman et al., “Controlled and Modulated Release of Basic Fibroblast Growth Factor,” Biomaterials (1991) 12:619-626.
Elofsson et al., Chemistry & Biology (1999) 6:811-822.
Ferretti, “Perspectives of pQct Technology Associated To Biomechanical Studies in Skeletal Research Employing Rat Models,” Bone (1995) 17:353S-364S.
Figueiredo-Pereira et al., “A New Inhibitor of the Chymotrypsin-Like Activity of the Multicatalytic Proteinase Complex (20S Proteasome) Induces Accumulation of Ubiquitin-Protein Conjugates in a Neuronal Cell,” J Neurochem (1994) 63:1578-1581.
Franzoso et al., “Requirement for NF-kB in Osteoclast and B-Cell Development,” Genes and Dev (1997) 11:3482-3496.
Garrett et al, “Specific Inhibitors of the Chymotryptic Component of the Proteasome are Potent Bone Anabolic Agents In Vivo” Journal of Bone and Mineral Research (2000) 15(Suppl.1)S197.
Gat et al., “De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin,” Cell (1998) 95:605-614.
Ghosh-Choudhery et al., “Immortalized Murine Osteoblasts Derived from BMP 2-T-Antigen Expressing Transgenic Mice,” Endocrinology (1996) 137:331-339.
Gowan et al., “Actions of Recombinant Interleukin 1, Interleukin 2, and Interferon-γ on Bone Resorption in Vitro,” J Immunol (1986) 136:2478-2482.
Groll et al., J. Am. Chem. Soc. (2000) 122:1237-1238.
Guijarro et al. “Lovastatin Inhibits Lipopolysaccharide-induced NF-kB Activation in Human Mesangial Cells,” Nephrol Dial Transplant (1996) 11:990-996.
Gupta et al., “Oral Cyclosporine for the Treatment of Alopecia Areata,” J Amer Acad of Dermatology (1990) 22(2):242-250.
Hardy et al., “The Secret Life of the Hair Follicle,” Trans Genet (1992) 8:55-61.
Harris et al. “Effects of Transforming Growth Factor β on Bone Nodule Formation and Expression of Bone Morphogenetic Protein 2, Osteocalcin, Osteopontin, Alkaline Phosphatase, and Type I Collagen mRNA in Long-Term Cultures of Fetal Rat Calvarial Osteoblasts,” J Bone Miner Res (1994) 9:855-863.
Hilt, W. et al., “Proteasomes: Destruction as a Programme,” Trans Biochem Sci 9(1996) 21:96-101.
Iotsova et al., “Osteopetrosis in Mice Lacking NF-kB1 and NF-kB2,” Nature Med (1997) 3:1285-1289.
Jensen, T.J. et al., “Multiple Proteolytic Systems, Including the Proteasome, Contribute to CFTR Processing,” Cell (1995) 83:129-135.
Kamiya et al., J. Derm. Sci. (1998) 17:54-60.
Kim et al., “Preparation of Multivesicular Liposomes,” Biochim Biophys Acta (1983) 728:339-348.
Kimmel et al., “The Effect of Recombinant Human (1-84) or Synthetic Human (1-34) Parathyroid Hormone on the Sleeton of Adult Osteopenic Ovariectomized Rats,” Endocrinology (1993) 132:1577-1584.
Ksander et al., “Exogenous Transforming Growth Factor-Beta 2 Enhances Connective Tissue Formation and Wound Strength in Guinea Pig Dermal Wounds Healing by Secondary Intent,” Ann Surg (1990) 211(3):288-294.
Laval-Jeantet et al., “Dual-EnergyX-Ray Absorptiometry of the Calcaneus: Comparison with Vertebral Dual-Energy X-Ray Absorptiometry and Quantitative Computed Tomography,” Calcif Tissue Intl (1995) 56:14-18.
Law et al., Mol. Cell Biol. (1992) 12:103-111.
Leserman et al., “Targeting to Cells of Fluorescent Liposomes Covalently Coupled With Monoclonal Antibody or Protein A,” Nature (1980) 288:602-604.
Liptay et al., “Inhibition of Nuclear Factor Kappa B and Induction of Apoptosis in T-Lymphocytes by Sulfasalazine,” Br J Pharmacol (1999) 128(7):1361-1369.
Lutz, “Effects of Cyclosporin A on Hair,” Skin Pharmacology (1994) 7:101-104.
Majeska et al., “Maintenance of Parathyroid Hormone Response in Clonal Rat Osteosarcoma Lines,” Exp Cell Res (1978) 111:465-467.
Maupin-Furlow, J.A. et al., A Proteasome from the methanogenic Archaeon Methanosarcina thermophila, J Biol Chem (1995) 270:28617-28622.
Wahl et al., “Sulfasalazine: A Potent and Specific Inhibitor of Nuclear Factor Kappa B,” J Clin Invest (1998) 101(5):1163-1174.
Wang et al., “Lipid Clearing Agents in Steroid-Induced Osteoporosis,” J Formos Med Assoc (1995) 94:589-592.
Wojick et al., “Ubiquitin-Mediated Proteolysis Centers in HeLa Cells: Indication from Studies of an Inhibitor of the Chymotrypsin-Like Activity of the Proteasome,” Eur J Cell Biol (1996) 71:311-318.
Wozney, “The Bone Morphogenetic Protein Family as Osteogenesis,” Molec Reprod Dev (1992) 32:160-167.
Mayer et al., “Vesicles of Variable Sizes Produced by a Rapid Extrusion Procedure,” Biochim Biophys Acta (1986) 858:161-168.
Meng et al., “Epoxomicin, a Potent and Selective Proteasome Inhibitor, Exhibits In Vivo Antiinflammatory Activity” Proceedings of the National Academy of Sciences of the United States (1999) 96(18):10403-10408.
Mundy et al., Science (1999) 286:1946-1949.
Murray et al., “The Ubiquitin-Proteasome System and Cellular Proliferation and Regulation in Osteoblastic Cells,” Experimental Cell Research (1998) 242:460-469.
Olson et al., “Preparation of Liposomes of Defined Size Deistribution by Extrusion Through Polycarbonate Membranes,” Biochim Biophys Acta (1979) 557:9-23.
Orford et al., “Serine Phosphorylation-Regulated Ubiquitination and Degradation of β-Catenin,” J Biol Chem (1997) 272:24735-24738.
Ozaki et al., “NF-kB Inhibitors Stimulate Apoptosis of Rabbit Mature Osteoclasts and Inhibit Bone Resorption by these Cells,” Febs Letters (1997) 410:297-300.
Pahl et al., “The Immunosupressive Fungal Metabolite Gliotoxin Specifically Inhibits Transcription Factor NF-kB,” J Exp Med (1996) 183:1829-1840.
Patent Abstracts of Japan (Aug. 12, 1993) 17:436 (C-1096).
Patent Abstracts of Japan (Jun. 20, 1987) 11:193 (C-430).
Patent Abstracts of Japan (Apr. 25, 1986) 10:112 (C-342).
Peters, J. “Proteasomes: Protein Degradation Machines of the Cell,” Trends Biochem Sci (1994) 19: 377-382.
Rickard et al., “Induction of Rapid Osteoblast Differentiationin Rat Bone Marrow Stromal Cell Cultures by Dexamethasone and BMP-2,” Develop Biol (1994) 161:218-228.
Sampath et al., “Isolation of Osteogenin, an Extracellular Matrix-Associated, Bone-Inductive Protein, by Heparin Affinity Chromatography,” Proc Natl Acad Sci USA (1987) 84:7109-7113.
Sin, N. et al., “Total Synthesis of the Potent Proteasome Inhibitor Epoxomicin: A Useful Tool for Understanding Proteasome Biology,” Biorg Med Chem Lett (1999) 9:2283-2288.
Szoka et al., “Procedure for Preparation of Liposomes With Large Internal Aqueous Space and High Capture by Reverse-Phase Evaporation,” Proc Natl Acad Sci USA (1978) 75:4194-4198.
Tencer et al., “The Effect of Local Controlled Release of Sodium Fluoride on the Stimulation of Bone Growth,” J Biomed Mat Res (1989) 23:571-589.
Vinitsky et al., “Inhibition of the Proteolytic Activity of the Multicatalytic Proteinase Complex (Proteasome) by Substrate-Related Peptidyl Aldehydes,” J Biol Chem. (1994) 269(47):29860-29866.
January 15, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
